# A Phase 1 Study to Investigate FP008 in Subjects With Advanced Solid Tumors

> **NCT06990698** · PHASE1 · RECRUITING · sponsor: **Zhuhai Fapon Biopharma Co., Ltd.** · enrollment: 108 (estimated)

## Conditions studied

- Advanced Solid Tumors

## Interventions

- **DRUG:** FP008 for injection

## Key facts

- **NCT ID:** NCT06990698
- **Lead sponsor:** Zhuhai Fapon Biopharma Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-06-12
- **Primary completion:** 2028-05
- **Final completion:** 2028-09
- **Target enrollment:** 108 (ESTIMATED)
- **Last updated:** 2025-10-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06990698

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06990698, "A Phase 1 Study to Investigate FP008 in Subjects With Advanced Solid Tumors". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06990698. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*